Search research articles
Contact Us
Filters
Showing results (1611-1620 of 1,669) with videos related to
Page
of 167
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2021
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W Ho, Igor L Gomes-Santos, Shuichi Aoki, et al.
Cell
|
September 4, 2012
A census of human soluble protein complexes
Pierre C Havugimana, G Traver Hart, Tamás Nepusz, et al.
The Lancet. Oncology
|
September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
Alice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
JCO Precision Oncology
|
June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer
Harshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
British Journal of Cancer
|
June 25, 2014
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
A F Hezel, M S Noel, J N Allen, et al.
JCO Precision Oncology
|
July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer
Susan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Nature Medicine
|
January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
Cancer Discovery
|
February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal Cancer
Mehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
The Lancet. Oncology
|
September 8, 2012
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
D Ross Camidge, Yung-Jue Bang, Eunice L Kwak, et al.
Page
of 167
Search research articles
Search
Showing results (1611-1620 of 1,669) with videos related to
Sort By:
Page
of 167
Proceedings of the National Academy of Sciences of the United States of America
|
November 2, 2021
Dendritic cell paucity in mismatch repair-proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
William W Ho, Igor L Gomes-Santos, Shuichi Aoki, et al.
Cell
|
September 4, 2012
A census of human soluble protein complexes
Pierre C Havugimana, G Traver Hart, Tamás Nepusz, et al.
The Lancet. Oncology
|
September 22, 2011
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis
Alice T Shaw, Beow Y Yeap, Benjamin J Solomon, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
JCO Precision Oncology
|
June 21, 2023
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer
Harshabad Singh, Samuel J Klempner, Nelya Melnitchouk, et al.
British Journal of Cancer
|
June 25, 2014
Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
A F Hezel, M S Noel, J N Allen, et al.
JCO Precision Oncology
|
July 12, 2021
Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer
Susan G R McDuff, Karin M Hardiman, Peter J Ulintz, et al.
Nature Medicine
|
January 28, 2004
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Christopher G Willett, Yves Boucher, Emmanuelle di Tomaso, et al.
Cancer Discovery
|
February 13, 2018
Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in <i>BRAF</i><sup>V600E</sup> Colorectal Cancer
Mehlika Hazar-Rethinam, Marianna Kleyman, G Celine Han, et al.
The Lancet. Oncology
|
September 8, 2012
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
D Ross Camidge, Yung-Jue Bang, Eunice L Kwak, et al.
Page
of 167